header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

THE MICROBIOLOGY OF THE INFECTED TOTAL HIP REPLACEMENT



Abstract

We retrospectively analysed three hundred and one infected total hip replacements. Infection was defined on the basis of the surgeons clinical impression. This included a thorough history and physical examination, laboratory and radiographic evaluation. Peri operative findings were also taken into consideration.

Despite the overt appearances of sepsis fifty seven of these three hundred and one cases demonstrated no bacterial growth. These were excluded from the microbiological analysis.

The remaining two hundred and forty four cases oven bacteriological evidence of deep infection. Thirty seven cases grew two different organisms both of which were felt to be clinically significant. The remainder grew a single organism. Hence a total two hundred and eighty one bacteriological isolates were grown.

Coagulase negative staphylococcus accounted for 54.8%, staphylococcus aureus 13.5%, streptococci 8.9%, Escherichia coli 6.1% and diptheroids 2.5%.These organisms were plated out in a standard fashion against a variety of antimicrobial agents.

We analysed ten antibiotics and their sensitivity profiles against the spectrum of organisms demonstrated by this series.

Best antimicrobial coverage by a single antibiotic was afforded by fucidic acid (85.3%) and erythromycin (79.6%). Gentamicin was found to be sensitive to only 76.1% of the bacteria present at the time of revision for deep infection.

Combining gentamicin with other antibiotics improved the theoretical coverage. A combination of gentamicin and fucidic acid demonstrated a 97.5% coverage. Gentamicin with erythromycin gave 95.2%.

When treating the infected arthroplasty it may be beneficial to add extra antibiotics to bone cement. This may either be to the cement spacer in a two stage revision or to the definitive cement in a single stage revision. We would suggest that fucidic acid or erythromycin would be good candidates for this. These candidates should also be considered when designing the next generation of combination antibiotic acrylic bone cements.

The abstracts were prepared by Mr Simon Donell. Correspondence should be addressed to him at the Department of Orthopaedics, Norfolk & Norwich Hospital, Level 4, Centre Block, Colney Lane, Norwich NR4 7UY, United Kingdom.